As summarized in Tables 2 and 3, multivariable analyses revealed that apart from CA-199, lymph node metastasis and tumor multiplicity, CD86+/CD206+ TAMs model remained to be the independent prognostic indicator for both OS (p = 0.003) and RFS (p = 0.005). The gene discussed is CD86; the disease is metastatic malignant neoplasm in the lymph nodes.